Se-Se Yennes joined Azurity Pharmaceuticals (formerly CutisPharma) as Executive Director, Corporate Strategy in April 2019. Se-Se is a senior healthcare executive with over 20 years of broad, global experience in business development, sales and marketing, including product launches, new product planning, in-line marketing, consultative services and licensing. She previously served as General Manager and Vice President for Cardinal Health with responsibility for solution development and delivery for key, strategic health systems, as well as leadership of the strategic account executive team.
Se-Se’s healthcare career includes serving in leadership positions with global pharmaceutical manufacturing, acute care, pharmaceutical consulting and distribution providers. She has led cross functional teams in transformational organizational change, led the launch of new business lines and established new business units in start -up situations to rapidly develop solutions. At Abbott Laboratories, and more recently, Johnson and Johnson, she served in Brand Manager and Brand Director roles for multiple well-known pharmaceutical brands including Humira, Norvir, Kaletra, Mobic and Prezista.
Se-Se is an active supporter of diversity inclusion and gender partnerships, and has been recognized by Columbus magazine. She serves on the board of Equitas Health and was recognized as Strayer University Alumni of the year. She received an MBA from Strayer University and a B.A in Communications from the University of Pittsburgh. She is a published author and fluent in Spanish.
Azurity Pharmaceuticals™, Inc. was formerly known as CutisPharma®, Inc. Product packaging may reflect either name.
All product imagery is for representation purposes only - not actual labels.
© 2020 Azurity Pharmaceuticals™, Inc. All Rights Reserved.